CD274 and melanoma: The analysis of melanoma tumors revealed that 38% of them express both PD-L1 and tumor-infiltrating lymphocyte (TIL), while 41% are negative for both, and 1% are PD-L1-positive, and 20% are TIL-positive [38,54,55].